Global Market Study on Infection Surveillance Solutions: North America to Hold High Value Share Throughout the Forecast Period 2017- 2025


Infection Surveillance Solutions Market
  • Published On : Jun-2017 |
  • Pages : 271 Pages |
  • Format :

About the Report

Persistence Market Research presents a comprehensive report on the global infection surveillance solution market titled ‘Infection Surveillance Solution Market: Global Industry Analysis 2013–2016 and Forecast 2017–2025’. The report starts with an executive summary that presents key findings related to the infection surveillance solution market such as pertinent market numbers and the CAGR from 2017 till 2025, and market forecast numbers related to various segments by component, by deployment type and by end user. The executive summary also lists the region-wise CAGR and the market value of the infection surveillance solution market in the year 2017 and 2025. At the end of the executive summary, there is a list of various drivers, restraints and trends operating in the global infection surveillance solution market that gives a cursory overview of the factors influencing the growth of this market. In addition, there is a list of prominent market players operating in the global infection surveillance solution market. After the executive summary, there is a section on market introduction that defines infection surveillance solutions and the capabilities of this software. The market introduction also consists of the definitions of various end users in the infection surveillance solution market.

Market Taxonomy

By Component

  • Software
  • Services
    • Implementation
    • Support & Maintenance
    • Training & Consulting

By Deployment Type

  • On-Premise
  • Web-Based

By End User

  • Hospitals
  • Clinics
  • Ambulatory Service Centers
  • Specialty Centers
  • Others

By Region

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East and Africa

After the market taxonomy, a market overview of the global infection surveillance solution market is presented, which is followed by a detailed and comprehensive section on the key market dynamics. In this section, the drivers, restraints and opportunities operating in the global infection surveillance solution market are discussed in detail and all the factors that encourage the growth of infection surveillance solutions as well as hamper the growth of this market are listed and a detailed explanation for the same is provided. After this section, a value chain analysis of the global infection surveillance solution market is given. This is followed by global infection surveillance solution market value analysis for 2013-2016 and forecast for 2017-2025. A section of the report highlights the market snapshot of the global infection surveillance solution market that gives segment-wise values of the infection surveillance solution market for the years 2017 and 2025. The subsequent sections of the report detail the global infection surveillance solution market by component, deployment type, end user and region. In these sections, important market forecast figures related to Basis Point Share analysis, year-on-year growth analysis, absolute dollar opportunity analysis and market attractiveness analysis are given.

Last but not the least, there is an entire section of the report devoted to the competition landscape of the global infection surveillance solution market. This competition landscape gives a dashboard view of the key companies operating in the global infection surveillance solution market. Each of the leading companies is also profiled individually and important information about the company such as company details, company description, product portfolio along with key developments concerning the company and strategic analysis is presented. This competition landscape is the most important section of the report as it imparts a deep understanding of the leading companies operating in the global infection surveillance solution market and is valuable for new entrants in the field to get a learning about how the companies are leading this lucrative market and also for established market players to get a better understanding about their competitors.       

Research Methodology

Overall market size has been analyzed through historical data, primary responses, and public domain data. Revenue of companies operating in the global infection surveillance solution market has been benchmarked to ascertain the market size for the base year. Macroeconomic indicators such as GDP and industry growth have been considered to forecast the market size over the forecast period. The historical growth trend of end-use industries, market participants’ performance, as well as the present macro-economic outlook has been taken into consideration for estimating the overall market trend forecast. This data is then validated with using the triangulation method and is extensively scrutinized using advanced tools to garner quantitative and qualitative insights into the global infection surveillance solution market.

Persistence Market Research forecasts revenue from the global infection surveillance solution market to increase from more than US$ 300 Mn in 2017 to about US$ 905 Mn by 2025 end, representing a CAGR of 14.04% from 2017 to 2025. The global infection surveillance solution market is expected to represent incremental opportunity of nearly US$ 600 Mn between 2017 and 2025.

Increasing occurrences of hospital associated infections (HAIs) boosting the global infection surveillance solution market

Hospital associated infections in a clinical setting, such as surgical site infections, urinary tract infection, and pneumonia are increasing due to contaminated devices and equipment, bed linens and patient clothing and others. This has prompted healthcare professionals and hospitals to adopt infection surveillance systems to identify possible healthcare associated infections in the duration of patient stay in hospitals and to assist in evaluating preventive measures. These infection surveillance solutions also aid in diagnosing antibiotic resistant organisms (AROs) and infections due to non-sanitized medical devices. The diagnosis of AROs involves data collection of antibiotic susceptibility test results and correlation of this data with geographical and clinical data for patient populations from whom pathogens were isolated, resulting in detecting an epidemic and facilitating necessary formulations.

Better compliance and reporting strengthening the infection surveillance solution market

In healthcare institutes, infection surveillance systems are incorporated for seeking accurate information on patient health, employee health, surgical databases, and medical records in real-time monitoring. Infection surveillance systems are used to access dashboards that work as key performance indicators and design reports pertaining to organizational compliance and infection trends, which further helps doctors and clinical staff offer accurate treatment to patients.

Inadequate data management and computing resources hampering the market for infection surveillance solutions

Improper data management leads to insufficient and incorrect data of patient’s medical history and care, which results in inappropriate inferences in surveillance systems. This might lead to difficulty in timely processing of patient data and their surgical history, and this is a factor expected to adversely affect growth of the infection surveillance market globally to a certain extent over the next few years. Increasing volume of data for analysis from different sources such as Enterprise Risk Management (ERM) and HR software along with changing regulatory requirements to calculate and analyze data decreases the efficiency of infection surveillance systems to accurately identify potential infections in patients.

Advancement in IT infrastructure offers a great opportunity to players in the infection surveillance solution market

Increased capacity of IT systems to perform analytic processing coupled with technological advancements in IT systems is aiding in developing analytical and infection surveillance solutions for application in the healthcare industry. These solutions include usage of algorithms with electronic medical records, specialized data mining software, and fully automated HAI surveillance by employing clinical support based knowledge that helps in identification of certain clinical terms. Various developments in surveillance solutions is making it simpler for health and clinical setting staff to better understand surveillance software and its usage, which results in creating a skilled workforce in the healthcare industry.

Global Infection Surveillance Solution Market Attractiveness by Region, 2017–2025

Revenue from the North America infection surveillance solution market is estimated to reach a value of more than US$ 180 Mn and account for 57.3% revenue share in 2017. The North America market is expected to be valued at nearly US$ 570 Mn and account for 62.4% in terms of revenue share by 2025 end. Revenue from the Europe market is also expected to witness high growth during the forecast period. The Europe infection surveillance solution market is estimated to be valued at about US$ 58 Mn and account for 18.2% value share in 2017. The Europe market is projected to reach a value of about US$ 163 Mn, and account for 18% revenue share by 2025 end.

infection surveillance solution market

Increasing adoption of infection surveillance systems due to federal mandates

Hospitals and healthcare facilities in North America are increasingly adopting infection surveillance systems due to federal mandates for implementation of clinical surveillance systems. Infection surveillance software enables healthcare institutes to detect infections on time. Surveillance software in hospitals aids in managing electronic healthcare records and real-time pharmacy and lab reports in order to identify if a patient has developed a HAI, thereby facilitating timely treatment of the infection.

Company Profiles

  • Becton Dickson & Company
  • Baxter International
  • Premier, Inc.
  • Truven Health Analytics Inc. (IBM Watson)
  • Gojo Industries, Inc.
  • RL Solutions
  • Wolters Kluwer N.V.
  • Vigilanz Corporation
  • Atlas Medical Software (Rpoer Technologies)
  • Quantros, Inc.
  • BD Diagnostics
  • ICNet Systems, Inc. (Baxter International)
  • Vecna Technologies, Inc.
  • bioMerieux, Inc.
  • Hygreen Inc.
  • Emerald Health Information Systems Ltd
  • DEB Group Ltd.
  • Iatric Systems, Inc.
  • PeraHealth Inc.
  • Cerner Corporation
  • Others.
Back To Top